Japan may open door to more foreign-approved drugs

Here's another hint of Japan's new openness to Big Pharma: a proposed compassionate use program. The government is considering allowing drugs for serious diseases to be sold in Japan while they're still in clinical trials there, so long as they're approved in foreign markets such as the U.S. or Europe. Report